Contraceptive prevalence, any modern method in Mexico
Mexico: Contraceptive prevalence, any modern method was 51.1% in 2023. ▲ Rising
Contraceptive prevalence, any modern method in Mexico, 1987–2023
Source: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of all women ages 15-49.
Analysis
The most recent figure for contraceptive prevalence, any modern method in Mexico is 51.1%, measured in 2023. That is the highest value across all 5 years on record.
The figure is up 4.1% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Mexico peaked at 51.1% in 2023 and was at its lowest, 28.9%, in 1987.
That places Mexico 13th out of 62 countries with data for 2023, putting it in the top quarter.
Contraceptive prevalence, any modern method in Mexico, year by year
| Year | % of all women ages 15-49 | Change |
|---|---|---|
| 1987 | 28.9% | — |
| 2009 | 46.8% | +61.8% |
| 2014 | 49.1% | +5.1% |
| 2015 | 50.5% | +2.7% |
| 2023 | 51.1% | +1.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 28.9% | 28.9% | 28.9% | 1 |
| 2000s | 46.8% | 46.8% | 46.8% | 1 |
| 2010s | 49.8% | 49.1% | 50.5% | 2 |
| 2020s | 51.1% | 51.1% | 51.1% | 1 |
Countries ranked near Mexico
- 11 Ecuador 52.9% compare
- 12 Paraguay 51.4% compare
- 14 United States of America 50.8% compare
- 15 Malawi 48.9% compare
- 16 Dominican Republic 48.2% compare
More health data for Mexico
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6599 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,312 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,760 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate -0.9607 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0377 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.9678 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Mexico?
- Contraceptive prevalence, any modern method in Mexico was 51.1% in 2023, according to Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Mexico?
- The highest recorded value was 51.1% in 2023.
- What is the lowest contraceptive prevalence, any modern method recorded in Mexico?
- The lowest recorded value was 28.9% in 1987.
- How does Mexico rank for contraceptive prevalence, any modern method?
- Mexico ranks 13th out of 62 countries with data for 2023.
- Is contraceptive prevalence, any modern method rising or falling in Mexico?
- Over the last ten years it is up 4.1%. The long-run trend across the full record is rising.
- Where does this Mexico data come from?
- The figures come from Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of all women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of all women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.